-
NUMBER OF INSIDER BUYING
(Last 12 Months)
1 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
0 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$9.01 M -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$0
Aligos Therapeutics, Inc. Insider Transactions
Aligos Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Nuechterlein Carole
Director, 10 percent owner: |
Buy | 7,933,601 @ $0.76 | $6.00 M | 11,025,941 | 10/25/2023 | 10/27/2023 | |
|
Nuechterlein Carole
Director, 10 percent owner: |
Buy | 3,966,800 @ $0.76 | $3.00 M | 3,966,800 | 10/25/2023 | 10/27/2023 |
Aligos Therapeutics, Inc. Frequently Asked Questions
-
Who is on Aligos Therapeutics, Inc.'s Insider Roster?
The list of insiders at Aligos Therapeutics, Inc. includes Nuechterlein Carole.
-
How much insider buying is happening at Aligos Therapeutics, Inc.?
Insiders have purchased a total of 11.90 M Aligos Therapeutics, Inc. shares in the last 12 months for a total of 9.01 M sold.
-
Which Aligos Therapeutics, Inc. insiders have been buying company stock?
The following insiders have purchased Aligos Therapeutics, Inc. shares in the last 12 months: Nuechterlein Carole ($9.01 M),